Back to SYRE
Janus Henderson Group Ltd. → SYRE
Janus Henderson Group Ltd. SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
9
Latest value
$8.5M
Q3 2026
Peak value
$248.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $701K |
| Q4 2025 | $59.2M |
| Q1 2026 | $1.1M |
| Q1 2026 | $82.5M |
| Q1 2026 | $1.1M |
| Q1 2026 | $82.5M |
| Q3 2026 | $248.8M |
| Q3 2026 | $527K |
| Q3 2026 | $8.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $8.5M | 94.9K | — | — |
| Q3 2026 | $527K | 5.9K | — | — |
| Q3 2026 | $248.8M | 2.79M | — | — |
| Q1 2026 | $82.5M | 1.63M | — | — |
| Q1 2026 | $1.1M | 21.4K | — | — |
| Q1 2026 | $82.5M | 1.63M | — | — |
| Q1 2026 | $1.1M | 21.4K | — | — |
| Q4 2025 | $59.2M | 1.81M | — | — |
| Q4 2025 | $701K | 21.4K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M
$336.7M